Researchers at Memorial Sloan-Kettering Cancer Center have pioneered the use of computerized devices to help patients and their physicians decide among the major treatment choices for several cancers.
Rather than relying on general risk groups of patient populations who share similar characteristics, our prediction tools provide specific information.
Our currently available tools include:
- those that predict outcomes for surgery and radiation therapy in prostate cancer, renal cell carcinoma, and sarcoma
- a tool that predicts survival for men with prostate cancer considering hormone refractory treatment (HRT) after prostatectomy or radiation therapy
- a tool that predicts the probability that a patient's prostate cancer will recur after radical prostatectomy
- a tool that predicts the probability that prostate cancer reoccurrence can be successfully treated with salvage radiation therapy
- tools that predicts the chance of breast cancer's spread to the sentinel lymph nodes and from the sentinel lymph nodes to axillary lymph nodes
- tools that predicts patient risk after surgery for gastric cancer
- a tool to help assess lung cancer risk of long-term cigarette smokers
- tools designed to assist physicians in predicting a patient's probability and length of survival after pancreatic and bladder cancer surgery
- a tool to help predict the probability of being disease-free from colon cancer after surgery
- a tool that predicts the likelihood that disease has spread to lymph nodes in patients with melanoma
- a tool that predicts overall survival after recieving primary therapy for endometrial cancer
- a tool that can be used for patients with gastrointestinal stromal tumors (GIST) to predict the chance they will survive without their cancer returning after receiving surgery
To use the prediction tools online, make a selection from the menu below.
